Home LiteratureArticle Details
PMID: 21987488 Published · ppublish English Journal Article Research Support, N.I.H., Extramural

Ethnicity and nonalcoholic fatty liver disease.

Hepatology (Baltimore, Md.) ·Vol. 55 ·No. 3 ·2012-03-00 ·Pages 769-80

Bambha K, Belt P, Abraham M, Wilson LA, Pabst M, Ferrell L, Unalp-Arida A, Bass N, Nonalcoholic Steatohepatitis Clinical Research Network Research Group

Abstract

Nonalcoholic fatty liver disease (NAFLD) is the most common liver disorder in the United States; however, few data are available about racial and ethnic variation. We investigated relationships between ethnicity, NAFLD severity, metabolic derangements, and sociodemographic characteristics in a well-characterized cohort of adults with biopsy-proven NAFLD. Data were analyzed from 1,026 adults (≥18 years) in the Nonalcoholic Steatohepatitis Clinical Research Network (NASH CRN) from 2004 to 2008, for whom liver histology data were available within 6 months of enrollment. Associations between ethnicity (i.e., Latino versus non-Latino white) and NAFLD severity (i.e., NASH versus non-NASH histology and mild versus advanced fibrosis) were explored with multiple logistic regression analysis. We also investigated effect modification of ethnicity on metabolic derangements for NAFLD severity. Within the NASH CRN, 77% (N = 785) were non-Latino white and 12% (N = 118) were Latino. Sixty-one percent (N = 628) had NASH histology and 28% (N = 291) had advanced fibrosis. Latinos with NASH were younger, performed less physical activity, and had higher carbohydrate intake, compared to non-Latino whites with NASH. Gender, diabetes, hypertension, hypertriglyceridemia, aspartate aminotransferase (AST), platelets, and the homeostasis model assessment of insulin resistance (HOMA-IR) were significantly associated with NASH. Age, gender, AST, alanine aminotransferase, alkaline phosphatase, platelets, total cholesterol, hypertension, and HOMA-IR, but not ethnicity, were significantly associated with advanced fibrosis. The effect of HOMA-IR on the risk of NASH was modified by ethnicity: HOMA-IR was not a significant risk factor for NASH among Latinos (odds ratio [OR] = 0.93; 95% confidence interval [CI]: 0.85-1.02), but was significant among non-Latino whites (OR, 1.06; 95% CI: 1.01-1.11). Metabolic risk factors and sociodemographic characteristics associated with NASH differ by ethnicity. Additional insights into NASH pathogenesis may come from further studies focused on understanding ethnic differences in this disease.

MeSH Terms
Adult Biopsy Fatty Liver/epidemiology,ethnology Female Hispanic or Latino Humans Liver/pathology Liver Cirrhosis/epidemiology,ethnology,pathology Logistic Models Male Middle Aged Non-alcoholic Fatty Liver Disease Retrospective Studies Risk Factors Severity of Illness Index Socioeconomic Factors United States/epidemiology Whites
Authors & Affiliations
9 authors, click to expand affiliations / ORCID
Bambha Kiran
University of Colorado Denver, Aurora, CO 80045, USA. [email protected]
Belt Patricia
Abraham Maria
Wilson Laura A
Pabst Mark
Ferrell Linda
Unalp-Arida Aynur
Bass Nathan
Nonalcoholic Steatohepatitis Clinical Research Network Research Group
Investigators
108 investigators, click to expand
McCullough Arthur J
Brandt Patricia
Bringman Diane
Dasarathy Srinivasan
Dasarathy Jaividhya
Hawkins Carol
Liu Yao-Chang
Rogers Nicholette
McCullough Arthur J
Dasarathy Srinivasan
Pagadala Mangesh
Sargent Ruth
Yerian Lisa
Zein Claudia
Merriman Raphael
Nguyen Anthony
Abdelmalek Manal F
Buie Stephanie
Diehl Anna Mae
Gottfried Marcia
Guy Cynthia
Hanna Meryt
Kigongo Christopher
Killenberg Paul
Kwan Samantha
Pan Yi-Ping
Piercy Dawn
Smith Melissa
Srivastava Savita
Chalasani Naga
Cummings Oscar W
Ghabril Marwan
Klipsch Ann
Ragozzino Linda
Subbarao Girish
Tandra Sweta
Vuppalanchi Raj
Morris Andrea
Siegner Joan
Stewart Susan
Neuschwander-Tetri Brent A
Thompson Judy
Behling Cynthia
Collins Jennifer
Durelle Janis
Hassanein Tarek
Lavine Joel E
Loomba Rohit
Morgan Anya
Patton Heather
Sirlin Claude
Aouizerat Bradley
Bambha Kiran
Bass Marissa
Bass Nathan M
Ferrell Linda D
Gu Bo
Hameed Bilal
Pabst Mark
Rosenthal Monique
Steel Tessa
Yeh Matthew
Boyett Sherry
Contos Melissa J
Fuchs Michael
Jones Amy
Luketic Velimir A C
Puri Puneet
Sandhu Bimalijit
Sanyal Arun J
Sargeant Carol
Noble Kimberly
White Melanie
Ackermann Sarah
Kowdley Kris V
Park Jane
Pierce Tracey
Mooney Jody
Nelson James
Shaw Cheryl
Stead Alice
Wang Chia
Brunt Elizabeth M
Kleiner David E
Doo Edward C
Hoofnagle Jay H
Robuck Patricia R
Sherker Averell
Belt Patricia
Brancati Frederick L
Clark Jeanne M
Colvin Ryan
Donithan Michele
Green Mika
Hollick Rosemary
Isaacson Milana
Jin Wana K
Lydecker Alison
Mann Pamela
May Kevin P
Miriel Laura
Sternberg Alice
Tonascia James
Ünalp-Arida Aynur
Van Natta Mark
Vaughn Ivana
Wilson Laura
Yates Katherine
References (24)
24 references, click to expand
  1. Role of ethnicity in overweight and obese patients with nonalcoholic steatohepatitis.
    Hepatology. 2011 Sep 2;54(3):837-45 PMID: 21674556
  2. Nonalcoholic steatohepatitis clinical research network.
    Hepatology. 2003 Feb;37(2):244 PMID: 12540771
  3. Variant in PNPLA3 is associated with alcoholic liver disease.
    Nat Genet. 2010 Jan;42(1):21-3 PMID: 19946271
  4. Influence of ethnicity on histological differences in non-alcoholic fatty liver disease.
    J Hepatol. 2009 Apr;50(4):797-804 PMID: 19231016
  5. Design and validation of a histological scoring system for nonalcoholic fatty liver disease.
    Hepatology. 2005 Jun;41(6):1313-21 PMID: 15915461
  6. Clinical, laboratory and histological associations in adults with nonalcoholic fatty liver disease.
    Hepatology. 2010 Sep;52(3):913-24 PMID: 20648476
  7. Racial and ethnic distribution of nonalcoholic fatty liver in persons with newly diagnosed chronic liver disease.
    Hepatology. 2005 Feb;41(2):372-9 PMID: 15723436
  8. Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity.
    Hepatology. 2004 Dec;40(6):1387-95 PMID: 15565570
  9. Estimates of nutrient intake from a food frequency questionnaire: the 1987 National Health Interview Survey.
    J Am Diet Assoc. 1992 Aug;92(8):969-77 PMID: 1640041
  10. Influence of gender, race, and ethnicity on suspected fatty liver in obese adolescents.
    Pediatrics. 2005 May;115(5):e561-5 PMID: 15867021
  11. Association of PNPLA3 with non-alcoholic fatty liver disease in a minority cohort: the Insulin Resistance Atherosclerosis Family Study.
    Liver Int. 2011 Mar;31(3):412-6 PMID: 21281435
  12. Morbid obesity exposes the association between PNPLA3 I148M (rs738409) and indices of hepatic injury in individuals of European descent.
    Int J Obes (Lond). 2010 Jan;34(1):190-4 PMID: 19844213
  13. The histologic spectrum of liver disease in African-American, non-Hispanic white, and Hispanic obesity surgery patients.
    Am J Gastroenterol. 2009 Jan;104(1):64-9 PMID: 19098851
  14. Pioglitazone versus vitamin E versus placebo for the treatment of non-diabetic patients with non-alcoholic steatohepatitis: PIVENS trial design.
    Contemp Clin Trials. 2009 Jan;30(1):88-96 PMID: 18804555
  15. Compendium of physical activities: an update of activity codes and MET intensities.
    Med Sci Sports Exerc. 2000 Sep;32(9 Suppl):S498-504 PMID: 10993420
  16. Prevalence of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis among a largely middle-aged population utilizing ultrasound and liver biopsy: a prospective study.
    Gastroenterology. 2011 Jan;140(1):124-31 PMID: 20858492
  17. Epidemiology and natural history of NAFLD and NASH.
    Clin Liver Dis. 2007 Feb;11(1):1-16, vii PMID: 17544968
  18. A nonsynonymous gene variant in the adiponutrin gene is associated with nonalcoholic fatty liver disease severity.
    J Lipid Res. 2009 Oct;50(10):2111-6 PMID: 19738004
  19. Is NASH underdiagnosed among African Americans?
    Am J Gastroenterol. 2002 Jun;97(6):1496-500 PMID: 12094872
  20. Pioglitazone, vitamin E, or placebo for nonalcoholic steatohepatitis.
    N Engl J Med. 2010 May 6;362(18):1675-85 PMID: 20427778
  21. Physical activity recommendations, exercise intensity, and histological severity of nonalcoholic fatty liver disease.
    Am J Gastroenterol. 2011 Mar;106(3):460-8; quiz 469 PMID: 21206486
  22. Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease.
    Nat Genet. 2008 Dec;40(12):1461-5 PMID: 18820647
  23. The prevalence and etiology of elevated aminotransferase levels in the United States.
    Am J Gastroenterol. 2003 May;98(5):960-7 PMID: 12809815
  24. Ethnic differences in hepatic steatosis: an insulin resistance paradox?
    Hepatology. 2009 Mar;49(3):791-801 PMID: 19105205
Article Info
Journal
Hepatology (Baltimore, Md.)
Abbr.
Hepatology
ISSN
1527-3350
Published
2012-03-00
Pages
769-80
Language
English
Region
United States
NLM ID
8302946
PMCID
PMC3278533
Subset
IM
Grants
NIDDK NIH HHS · U01DK61738 · United States
NIDDK NIH HHS · U01 DK061718 · United States
NIDDK NIH HHS · U01DK61718 · United States
NIDDK NIH HHS · U01 DK061730 · United States
NCATS NIH HHS · UL1 TR000454 · United States
NIDDK NIH HHS · U01 DK061738 · United States
NIDDK NIH HHS · U01DK61713 · United States
NIDDK NIH HHS · U01 DK061738-08S1 · United States
NCRR NIH HHS · UL1 RR025008 · United States
NIDDK NIH HHS · U01DK61732 · United States
NIDDK NIH HHS · U01DK61734 · United States
NIDDK NIH HHS · U01 DK061737 · United States
NIDDK NIH HHS · U01 DK061713 · United States
NIDDK NIH HHS · U01 DK061732 · United States
NIDDK NIH HHS · U01DK61728 · United States
NIDDK NIH HHS · U01 DK061731 · United States
NIDDK NIH HHS · U01DK61731 · United States
NIDDK NIH HHS · U01 DK061728 · United States
NIDDK NIH HHS · U01DK61737 · United States
NIDDK NIH HHS · U01 DK061734 · United States
NIDDK NIH HHS · U01DK61730 · United States
Corrections
CommentIn
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]